|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.220 USD | -5.29% |
|
+1.90% | -32.49% |
| 03-06 | European Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Down 5% for Week | MT |
| 03-06 | Evaxion A/S, 2025 Earnings Call, Mar 06, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||
Biotechnology | - | - | 73K | 3.34M | - | |||
Total Assets | 40.16M | 22.02M | 12.89M | 12.48M | - | |||
Interest Expense | -159K | -798K | -897K | -962K | - | |||
Income Tax Expense | -178K | -772K | -790K | -788K | - | |||
CAPEX | -1.36M | -292K | -87K | - | - | |||
EBT | -24.71M | -23.94M | -22.92M | -11.36M | - | |||
D&A | 344K | 571K | 615K | 607K | - | |||
Operating Income | -25.83M | -25.26M | -22.2M | -14.73M | - | |||
Net Income | -24.53M | -23.17M | -22.12M | -10.57M | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
Denmark | - | - | 73K | 3.34M | - | |||
Total Assets | 40.16M | 22.02M | 12.89M | 12.48M | - | |||
Interest Expense | -159K | -798K | -897K | -962K | - | |||
Income Tax Expense | -178K | -772K | -790K | -788K | - | |||
D&A | 344K | 571K | 615K | 607K | - | |||
CAPEX | -1.36M | -292K | -87K | - | - | |||
Net Income | -24.53M | -23.17M | -22.12M | -10.57M | - | |||
EBT | -24.71M | -23.94M | -22.92M | -11.36M | - | |||
Operating Income | -25.83M | -25.26M | -22.2M | -14.73M | - |
- Stock Market
- Equities
- EVAX Stock
- Financials Evaxion A/S
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition